Discover
ADXN
Addex Therapeutics Ltd
5.89
7 x 5.60
1 x 5.97
bid
ask
+
0.00
0.00%
04:00 PM
timesize
| Ytd | -23.64% | |
| 1y | -27.40% |
5.64
day range
5.78
5.41
52 week range
12.05
| Open | 5.78 | Prev Close | 5.89 | Low | 5.64 | High | 5.78 | Mkt Cap | 4.25M |
| Vol | 0.00 | Avg Vol | 3.53K | EPS | -6.30 | P/E | -0.94 | Forward P/E | -159.83 |
| Beta | 1.50 | Short Ratio | 0.14 | Inst. Own | 0.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 6.30 | 200-d Avg | 7.39 | 1yr Est | 30.00 |
| Income Statement | |||
| Total Revenue | 7.69K | ||
| Revenues (USD) | 9.86K | ||
| Gross Profit | 7.69K | ||
| Operating Expenses | 487.52K | ||
| Research and Development Expense | 36.13K | ||
| Selling, General and Administrative Expense | 451.39K | ||
| Operating Income | -479.83K | ||
| Interest Expense | 2.66K | ||
| Net Income | -1.71M | ||
| Net Income Common Stock | -1.71M | ||
| Net Income Common Stock (USD) | -2.19M | ||
| Consolidated Income | -1.71M | ||
| Earnings per Basic Share | -0.01 | ||
| Earnings per Basic Share (USD) | -0.01 | ||
| Earnings per Diluted Share | -0.01 | ||
| Earning Before Interest & Taxes (EBIT) | -1.71M | ||
| Earning Before Interest & Taxes (USD) | -2.19M | ||
| Weighted Average Shares | 116.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 935.15K | ||
| Cash and Equivalents (USD) | 1.20M | ||
| Investments | 2.96M | ||
| Investments Current | 2.35K | ||
| Investments Non-Current | 2.96M | ||
| Trade and Non-Trade Receivables | 31.99K | ||
| Current Assets | 1.19M | ||
| Property, Plant & Equipment Net | 101.44K | ||
| Total Assets | 4.76M | ||
| Debt Current | 77.24K | ||
| Total Debt | 102.27K | ||
| Current Liabilities | 1.22M | ||
| Debt Non-Current | 25.03K | ||
| Total Liabilities | 1.47M | ||
| Accumulated Retained Earnings (Deficit) | -361.80M | ||
| Shareholders Equity | 3.29M | ||
| Shareholders Equity (USD) | 4.21M | ||
| Assets Non-Current | 3.57M | ||
| Total Debt (USD) | 131.11K | ||
| Liabilities Non-Current | 250.33K | ||
| Trade and Non-Trade Payables | 1.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 9.82K | ||
| Net Cash Flow from Financing | 65.43K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -700.42K | ||
| Issuance (Purchase) of Equity Shares | 70.33K | ||
| Issuance (Repayment) of Debt Securities | -1.55K | ||
| Net Cash Flow from Operations | -765.84K | ||
| Effect of Exchange Rate Changes on Cash | -3.04K | ||